GLYCIPHAGE VG-2 TAB
Rs 154.25 10 % Off
Package size
Estimate Delivery by:
Delivering to
Easy 7 days return available
GLYCIPHAGE VG-2 TAB
Glyciphage VG2 Tablet is a combination of Glimepiride, Metformin, and Voglibose designed for managing type 2 diabetes mellitus effectively. Glimepiride increases insulin secretion, Metformin decreases hepatic glucose production and enhances insulin sensitivity, while Voglibose slows carbohydrate digestion, reducing post-meal blood sugar spikes. This triple-action approach ensures better glycemic control for patients requiring more than diet and exercise alone. Common side effects include gastrointestinal issues and hypoglycemia. The medication is contraindicated for individuals with type 1 diabetes, severe kidney or liver conditions, and during pregnancy or breastfeeding. Regular monitoring, adherence to lifestyle changes, and consulting with a healthcare provider are essential for optimal results.
Product Highlights and Usage:
Triple Combination Therapy: Contains Glimepiride, Metformin, and Voglibose for comprehensive blood sugar control. Mechanism of Action: Stimulates insulin release, reduces glucose production, and slows carbohydrate digestion. Effective for Type 2 Diabetes: Ideal when diet, exercise, and dual therapy are insufficient. Common Side Effects: Hypoglycemia, nausea, diarrhea, stomach pain, and dizziness. Precautions: Not recommended for type 1 diabetes, severe kidney or liver disease, pregnancy, or breastfeeding.
How it works:
GLYCIPHAGE VG2 TABLET is used to manage type 2 diabetes mellitus. Glimepiride lowers blood glucose levels by increasing the amount of insulin released by the pancreas. Metformin decreases glucose production in the liver and the amount of glucose absorbed by the stomach and intestines. It also helps to restore the body’s response to insulin. Voglibose inhibits the alpha-glucosidase enzyme, which breaks down complex carbohydrates into simple sugars, thereby slowing down the digestion and absorption of carbohydrates in the small intestine. This combination effectively reduces blood glucose levels in individuals with type 2 diabetes mellitus.
Directions for use:
Take GLYCIPHAGE VG2 TABLET as advised by your physician. Swallow the medicine with a glass of water without crushing or chewing it. Your doctor will determine the correct dose and duration based on your age, body weight, and medical condition.
Warning & Precaution:
PREGNANCY GLYCIPHAGE VG2 TABLET is not recommended for use during pregnancy as it may cause harm to the fetus. Consult your doctor before taking this medication. BREASTFEEDING GLYCIPHAGE VG2 TABLET is not recommended for use in breastfeeding women as the medicine may pass through breast milk and harm the nursing child. Consult your doctor before taking this medication. DRIVING AND USING MACHINES Do not drive or operate any machines if you experience impaired alertness or reactions (due to hypoglycemia) while taking GLYCIPHAGE VG2 TABLET. ALCOHOL Do not consume alcohol while taking GLYCIPHAGE VG2 TABLET as it may reduce your blood sugar level. Consult your doctor for advice. KIDNEY GLYCIPHAGE VG2 TABLET is not recommended for patients with severe renal failure. It should be used with caution in patients with other kidney diseases. Consult your doctor before taking this medication. LIVER GLYCIPHAGE VG2 TABLET is not recommended for patients with severe liver disease. It should be used with caution in patients with other liver diseases. Consult your doctor before taking this medication. ALLERGY Do not take GLYCIPHAGE VG2 TABLET if you are allergic to glimepiride, metformin, voglibose, other sulfonylureas/sulphonamides, or any other ingredients of this medicine. LUNGS GLYCIPHAGE VG2 TABLET is not recommended for patients with lung problems such as acute or chronic respiratory failure. Consult your doctor before taking this medication. HEART DISEASE GLYCIPHAGE VG2 TABLET is not recommended for patients with heart problems such as acute or chronic cardiac failure or recent myocardial infarction. Consult your doctor before taking this medication. USE IN PEDIATRICS GLYCIPHAGE VG2 TABLET is not recommended for use in children and adolescents under 18 years as the safety and effectiveness of the medicine are not established. Consult your doctor before taking this medication. USE IN GERIATRICS GLYCIPHAGE VG2 TABLET should be used with caution in elderly patients aged 65 years and above. Consult your doctor before taking this medication.
Super Admin
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s
Recent Posts
-
October 18, 2015
-
October 18, 2015
Products
-
275$
-
137.64$